Of note, KRAS mutational status was not significantly associated with expression of SATB1, a global gene regulator that has been demonstrated to be an independent factor of poor prognosis in high-grade tumours in the here examined cohort [21], as well as in several other cancer forms, e.g. breast [42] and colorectal cancer [43,44]. The gene discussed is KRAS; the disease is cancer.